Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Fear and Trust in TKA Rehabilitation
NCT04493229Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in osteoarthritis of the knee (OA), sponsored by Wake Forest University Health Sciences. Planned start Jan 2024; status: withdrawn.
02
Drugs
oxytocin
03
Conditions
osteoarthritis of the knee (OA)
Beyond the preview
Go deeper on NCT04493229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04493229.